RxDoctor Payments Data

Richard Garza, MD

Surgery · Houston, TXNPI 1982782017

Payments from drug & device makers

$193in general payments, 2019–2025

Across 9 payments — averaging $21.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$46
  • Biotissue Holdings Inc.$43
  • AbbVie$33
  • Dendreon Pharmaceuticals LLC$33
  • Heartflow, Inc.$25
  • Davol Inc.$13

What the payments were for

  • Food & beverage$193100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$193 in reported general payments places this provider in the 15th percentile of 1,830 surgery providers in Texas.

See all surgery providers in Texas

Medicare billing

Part B allowed, 2024
$245,854
Medicare patients
325
Services billed
1,433

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tramadol Hcl44$103

Paid to pharmacies, not to this prescriber.

Other surgery in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →